Document is current
Any future updates will be listed below
-
Authors
Herron, Lissa R. http://orcid.org/0000-0001-9961-4421
Pridans, Clare
Turnbull, Matthew L.
Smith, Nikki
Lillico, Simon
Sherman, Adrian
Gilhooley, Hazel J.
Wear, Martin
Kurian, Dominic
Papadakos, Grigorios
Digard, Paul
Hume, David A.
Gill, Andrew C.
Sang, Helen M.
-
Funding
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BBS/E/D/20221658, BB/I013113/1, BB/M021920/1, BB/J01446X/1)
Wellcome Trust (081287/Z/06/Z, 101527/Z/13/Z)
Medical Research Council (MR/K000276/1)
- License Information
-
More Information
Article History
Received: 14 September 2018
Accepted: 18 December 2018
First Online: 29 December 2018
Ethics approval
: Approval for animal experiments was obtained from The Roslin Institute’s and The University of Edinburgh’s Protocols and Ethics Committees. The experiments were carried out under the authority of a UK Home Office Project License under the regulations of the Animals (Scientific Procedures) Act 1986.
: Not applicable.
: D.A.H. holds a patent position on the applications of CSF1-Fc in liver disease, and of CSF1 in kidney regeneration. Part of this work was performed on a collaborative grant part-funded by Zoetis, Inc. L.R.H. is now employed by Roslin Technologies, who will be commercializing the chicken platform, as well as the current proteins for use as research reagents.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
